![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Active Filter(s):
Details:
Under the agreement, Sipp Industries will manufacture SinuSave® CBD Nasal Spray products. SinuSave® CBD is proven to be bacteriostatic and bactericidal.
Lead Product(s): Cannabidiol
Therapeutic Area: Neurology Product Name: SinuSave
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: SinuSave
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement January 23, 2024